首页 | 本学科首页   官方微博 | 高级检索  
     


Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label,single-arm,phase 2 study
Authors:Katja Deterding  Christoph D Spinner  Eckart Schott  Tania M Welzel  Guido Gerken  Hartwig Klinker  Ulrich Spengler  Johannes Wiegand  Julian Schulze zur Wiesch  Anita Pathil  Markus Cornberg  Andreas Umgelter  Caroline Zöllner  Stefan Zeuzem  Armin Papkalla  Kristina Weber  Svenja Hardtke  Heiko von der Leyen  Heiner Wedemeyer
Affiliation:1. Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany;2. Department of Biostatistics, Hannover Medical School, Hannover, Germany;3. HepNet Study-House, German Liver Foundation, Hannover, Germany;4. Department of Medicine II, University Hospital Klinikum rechts der Isar, Munich, Germany;5. Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Berlin, Germany;6. Department of Medicine, University Hospital Frankfurt, Frankfurt, Germany;7. Department of Gastroenterology and Hepatology, University Hospital Essen, Essen, Germany;8. Department of Internal Medicine II, Division of Infectious Diseases, University of Würzburg Medical Center, Würzburg, Germany;9. Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany;10. Department of Gastroenterology and Rheumatology, Section of Hepatology, University of Leipzig, Leipzig, Germany;11. Department of Internal Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany;12. Department of Internal Medicine IV, Gastroenterology and Hepatology, University Clinic of Heidelberg, Heidelberg, Germany;13. German Centre for Infection Research (DZIF), partner site Hannover-Braunschweig, Germany;14. Hannover Clinical Trial Center, Hannover, Germany
Abstract:
Keywords:the
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号